Serum Institute of India continues to lead Indian biopharma industry at No 1 position

Pune-based vaccine manufacturer Serum Institute of India (SII) recorded a revenue of Rs 7201 crore during FY 20-21

Related Keywords

India ,United Kingdom ,Pune ,Maharashtra ,Prakash Kumar Singh ,University Of Oxford ,Serum Institute Of India Ltd ,Melinda Gates Foundation ,Indian Council Of Medical Research ,Vaccine Alliance ,Astrazeneca ,Sanofi Healthcare India Pvt Ltd ,Regulatory Affairs At Serum Institute ,Biocon Ltd ,Serum Institute Of India ,Pune Based Serum Institute ,India Ltd ,Indian Biopharmaceutical Industry ,Bangalore Based Biocon Ltd ,Hyderabad Based Sanofi Healthcare India Pvt Ltd ,Serum Institute ,Indian Council ,Medical Research ,Regulatory Affairs ,Vaccine ,